Importantly, higher CPscore determined significantly shorter OS and EFS and multivariate analysis showed that PP2A phosphorylation/inhibition is a recurrent alteration with an independent prognostic value in breast cancer. The gene discussed is PTPA; the disease is breast carcinoma.